Clik here to view.
Versant starts TSO3 at “buy”
Versant Partners initiated coverage of TSO3 (TSX:TOS) with a “buy” and 12-month price target of $2.50 after the maker of ozone-based sterilizers for healthcare markets won FDA approval last week to...
View ArticleClik here to view.
3M to distribute TSO3 sterilizer
TSO3 (TSX:TOS) has signed an agreement with 3M to be the exclusive distributor of its Sterizone 125L sterilization system. The accord “pairs innovation in technology with innovation in marketing, sales...
View ArticleClik here to view.
TSO3 gets boost from FDA decision
The FDA has advised U.S. health care administrators to discontinue use of Steris Corp.’s (NYSE:STE) peracetic acid-based endoscope reprocessing device System 1 within 18 months. In a research report,...
View ArticleClik here to view.
TSO3 in $16 million bought deal
TSO3 (TSX:TOS) has agreed to sell 10 million new shares at a price of $1.60 each in a bought deal to a syndicate of underwriters led by Canaccord Adams. The stock closed at $1.80 yesterday. Gross...
View ArticleClik here to view.
TSO3 new sterilizer system gets European okay
TSO3’s (TSX:TOS) new sterilization system was cleared for sale in Europe after meeting the European Union’s new medical device directive for Class IIb medical devices, allowing TSO3 to label its...
View ArticleClik here to view.
TSO3 to resubmit for U.S. clearance
TSO3 (TSX:TOS) has received instructions from U.S. regulatory authorities to resubmit a 510k for its Sterizone 125L + Sterilizer with “additional data” and to “better establish the link between the...
View Article
